  | Related Articles |
Of chloroquine and COVID-19.
Antiviral Res. 2020 05;177:104762
Authors: Touret F, de Lamballerie X
Abstract
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
PMID: 32147496 [PubMed - indexed for MEDLINE]